Assessing the efficacy of oral immunotherapy for the desensitisation of peanut allergy in children (STOP II): A phase 2 randomised controlled trial

The Lancet

Volumn 383, Issue 9925, 2014, Pages 1297-1304

  Anagnostou, Katherine ^a   Islam, Sabita ^a   King, Yvonne ^a   Foley, Loraine ^a   Pasea, Laura ^b   Bond, Simon ^a,c   Palmer, Chris ^b   Deighton, John ^a   Ewan, Pamela ^a   Clark, Andrew ^a  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; ANTIHISTAMINIC AGENT; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT;

ABDOMINAL PAIN; ADOLESCENT; ANGIONEUROTIC EDEMA; ARTICLE; CHILD; CHRONIC DISEASE; CLINICAL RESEARCH; CONTROLLED STUDY; CROSSOVER PROCEDURE; DESENSITIZATION; DIARRHEA; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; ERYTHEMA; FAINTNESS; FEMALE; FOOD INTAKE; HEALTH CARE QUALITY; HOUSEHOLD; HUMAN; IMMEDIATE TYPE HYPERSENSITIVITY; INTENTION TO TREAT ANALYSIS; INTERVENTION STUDY; LARYNX EDEMA; MAJOR CLINICAL STUDY; MALE; MOUTH ITCH; NAUSEA; ONLINE SYSTEM; ORAL IMMUNOTHERAPY; OUTCOME ASSESSMENT; PATIENT ASSESSMENT; PEANUT ALLERGY; PRICK TEST; PRIORITY JOURNAL; PRURITUS; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RHINITIS; SHOCK; SKIN TEST; URTICARIA; VOMITING; WHEEZING;

ADMINISTRATION, ORAL; ADOLESCENT; CHILD; CROSS-OVER STUDIES; DESENSITIZATION, IMMUNOLOGIC; ENGLAND; FEMALE; HUMANS; IMMUNOTHERAPY; MALE; PEANUT HYPERSENSITIVITY; QUALITY OF LIFE; SKIN TESTS; TREATMENT OUTCOME;

EID: 84898033917     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(13)62301-6     Document Type: Article

References (29)

1. Venter C, Arshad H, Grundy J, et al. Time trends in the prevalence of peanut allergy: three cohorts of children from the same geographical location in the UK. Allergy 2010; 65: 103-08.
2. Sicherer S, Munoz-Furlong A, Sampson H. Prevalence of peanut and tree nut allergy in the United States determined by means of a random digit dial telephone survey: a 5-year follow-up study. J Allergy Clin Immunol 2003; 112: 1203-07.
3. Pumphrey R, Gowland H. Further fatal allergic reactions to food in the United Kingdom, 1999-2006. J Allergy Clin Immunol 2007; 119: 1018-19.
4. Ho M, Wong W, Heine R, Hosking C, Hill D, Allen K. Early clinical predictors of remission of peanut allergy in children. J Allergy Clin Immunol 2008; 121: 731-36.
5. Primeau M, Kagan R, Joseph L, et al. The psychological burden of peanut allergy as perceived by adults with peanut allergy and the parents of peanut-allergic children. Clin Exp Allergy 2000; 30: 1135-43.
6. Avery N, King R, Knight S, Hourihane J. Assessment of quality of life in children with peanut allergy. Ped Allergy Immunol 2003; 14: 378-82.
7. Kapoor S, Roberts G, Bynoe Y, Gaughan M, Habibi P, Lack G. Influence of a multidisciplinary paediatric allergy clinic on parental knowledge and rate of subsequent allergic reactions. Allergy 2004; 59: 185-91.
8. Ewan P, Clark A. Long-term prospective observational study of the outcome of a management plan in participants with peanut and nut allergy referred to a regional allergy centre. Lancet 2001; 357: 111-15.
9. Sicherer S, Burks A, Sampson H. Clinical features of acute allergic reactions to peanut and tree nuts in children. Pediatrics 1998; 102: e6.
10. Clark A, Ewan P. Good prognosis, clinical features and circumstances of peanut and tree nut reactions in children treated by a specialist allergy centre. J Allergy Clin Immunol 2008; 122: 286-89.
11. Durham S, Emminger W, Kapp A, et al. Long-term clinical efficacy of grass-pollen immunotherapy. N Engl J Med 1999; 341: 468-75.
12. Calderon M, Alves B, Jacobson M, Hurwitz B, Sheikh A, Durham S. Allergen injection immunotherapy for seasonal allergic rhinitis. Cochrane Database Syst Rev 2007; 24: CD001936.
13. Boyle R, Elremeli M, Hockenhull J, et al. Venom immunotherapy for preventing allergic reactions to insect stings. Cochrane Database Syst Rev 2012; 10: CD008838.
14. Nelson H, Lahr J, Rule R, Bock A, Leung D. Treatment of anaphylactic sensitivity to peanuts by immunotherapy with injections of aqueous peanut extract. J Allergy Clin Immunol 1997; 99: 744-51.
15. Staden U, Rolinck-Werninghaus C, Brewe F, Wahn U, Niggemann B, Beyer K. Specific oral tolerance induction in food allergy in children: efficacy and clinical patterns of reaction. Allergy 2007; 62: 1261-69.
16. Longo G, Barbi E, Berti I, et al. Specific oral tolerance induction in children with very severe cow's milk-induced reactions. J Allergy Clin Immunol 2008; 121: 343-47.
17. Clark A, Islam S, King Y, Deighton J, Anagnostou K, Ewan P. Successful oral tolerance induction in severe peanut allergy. Allergy 2009; 64: 1218-20.
18. Anagnostou K, Clark A, King Y, Islam S, Deighton J, Ewan P. Efficacy and safety of high-dose peanut oral immunotherapy with factors predicting outcome. Clin Exp Allergy 2011; 41: 1273-81.
19. Niggemann B. When is an oral food challenge positive? Allergy 2010; 65: 2-6.
20. Keil T, McBride D, Grimshaw K, et al. The multinational birth cohort of EuroPrevall: background, aims and methods. Allergy 2010; 65: 482-90.
21. Flokstra-de Blok B, DunnGalvin A, Vlieg-Boerstra B, et al. Development and validation of a self-administered Food Allergy Quality of Life Questionnaire for children. Clin Exp Allergy 2009; 39: 127-37.
22. Tobin J. Estimation of relationships for limited dependent variables. Econometrica 1958; 26: 24-36.
23. Nurmatov U, Venderbosch I, Devereux G, Simons F, Sheikh A. Allergen-specific oral immunotherapy for peanut allergy. Cochrane Database Syst Rev 2012; 9: CD009014.
24. Barnett J, Leftwich J, Muncer K, et al. How do peanut and nut-allergic consumers use information on the packaging to avoid allergens? Allergy 2011; 66: 969-78.
25. Rimbaud L, Heraud F, La Vieille S, Leblanc J, Crepet A. Quantitative risk assessment relating to adventitious presence of allergens in food: a probabilistic model applied to peanut in chocolate. Risk Analysis 2010; 30: 7-19.
26. Leitch I, Walker M, Davey R. Food allergy: gambling your life on a take-away meal. Int J Env Health Res 2005; 15: 79-87.
27. Factor J, Mendelson L, Lee J, Nouman G, Lester MR. Effect of oral immunotherapy to peanut on food-specific quality of life. Ann Allergy Asthma Immunol 2012; 109: 348-52.
28. Blumchen K, Ulbricht H, Staden U, et al. Oral peanut immunotherapy in children with peanut anaphylaxis. J Allergy Clin Immunol 2010; 126: 83-91.
29. Jones S, Pons L, Roberts J, et al. Clinical efficacy and immune regulation with peanut oral immunotherapy. J Allergy Clin Immunol 2009; 124: 292-300.